期刊文献+

糖尿病周围神经病变与病程、2 h CP、Cys-C、UACR的相关性 被引量:6

Correlation between diabetic peripheral neuropathy and course of disease,2 h CP,Cys⁃C,UACR
下载PDF
导出
摘要 目的探讨胱抑素C(Cys-C)、餐后2小时C肽(2 h CP)、尿微量白蛋白/尿肌酐(UACR)、病程与2型糖尿病周围神经病变(DPN)的相关性。方法根据双下肢肌电图及足部定量感觉检查结果,选取庆阳市人民医院2021年1月至2022年1月的DPN患者100例作为观察组、2型糖尿病非周围神经病变(NDPN)患者73例作为对照组,收集患者的实验室数据及临床指标,分析Cys-C、2 h CP、UACR、病程等指标与DPN之间的相关性。结果DPN组空腹胰岛素(FINS)、尿免疫球蛋白G、尿肌酐、病程、Cys-C、UACR均显著高于NDPN组,差异有统计学意义(t=-2.728,-3.826,-2114,-2.632,-2.850,-2.717,P<0.05);2 h CP水平显著低于NDPN组,差异有统计学意义(t=2.696,P<0.05);Logisitc回归显示,糖尿病病程、2 h CP、Cys-C与DPN具有相关性,差异有统计学意义(OR=1.863,0.729,3.799,P<0.05);ROC曲线显示,病程、Cys-C、2 h CP、糖化血红蛋白(HbA1c)四项联合的诊断性能较好,其次是Cys-C。结论Cys-C、2 h CP、UACR、病程与DPN相关,可能是疾病发作的危险性因素,临床需对此引起高度重视。 Objective To investigate the correlation between cystatin C(Cys⁃C),2 hours postpran⁃dial C peptide(2 h CP),urinary microalbumin/urinary creatinine(UACR),disease duration and type 2 diabetic peripheral neuropathy(DPN).Methods According to the results of lower limb electromyography and foot quantitative sensory examination,100 DPN patients(observation group)and 73 patients(control group)with type 2 diabetes and non⁃peripheral neuropathy(NDPN)were selected from the People's Hospital of Qingyang City from January 2021 to January 2022.Laboratory data and clinical indicators of patients were collected.The correlation between DPN and Cys⁃C,2 h CP,UACR,disease course and other indicators was analyzed.Results Fasting insulin(FINS),urinary immunoglobulin G,urinary creatinine,disease course,Cys⁃C and UACR in the DPN group were significantly higher than those in the NDPN group,and the difference was statis⁃tical significance(t=-2.728,-3.826,-2114,-2.632,-2.850,-2.717,P<0.05).The levels of 2 h CP were sig⁃nificantly lower than those of the NDPN group,and the difference was statistical significance(t=2.696,P<0.05).Logisitc regression showed that the duration of diabetes,2 h CP and Cys⁃C were correlated with DPN,and the difference was statistical significance(OR=1.863,0.729,3.799,P<0.05).The ROC curve showed that the combination of disease course,Cys⁃C,2h CP,and HbA1c had better diagnostic performance,followed by Cys⁃C.Conclusions Cys⁃C,2 h CP,UACR,and course of disease are related to DPN,which may be risk factors of disease onset and clinical attention should be paid to them.
作者 刘艳 郑红军 章国平 侯娟娟 LIU Yan;ZHENG Hongjun;ZHANG Guoping;HOU Juanjuan(Department of Endocrinology,the People's Hospital of Qingyang City,Qingyang,Gansu,China,745000;Department of Clinical Laboratory Medicine,the People's Hospital of Qingyang City,Qingyang,Gansu,China,745000;Department of Clinical Laboratory Medicine,the Hospital of Maternity and Child-care Gan-su Province,Lanzhou,Gansu,China,730050)
出处 《分子诊断与治疗杂志》 2023年第6期964-967,共4页 Journal of Molecular Diagnostics and Therapy
基金 甘肃省陇原青年创新人才项目(2021LQGR05)。
关键词 2型糖尿病周围神经病变 胱抑素C 餐后2小时C肽 尿微量白蛋白/尿肌酐 Type 2 diabetic peripheral neuropathy Cys⁃C C peptide 2 hours after meal UACR
  • 相关文献

参考文献15

二级参考文献114

  • 1黄沛隆.血C肽和胰岛素测定在2型糖尿病中的应用[J].实用医技杂志,2005,12(02A):336-336. 被引量:10
  • 2苏宏业,黄媛,黄炫赓.2型糖尿病患者空腹C肽分泌影响因素研究[J].广西医科大学学报,2010,27(5):700-701. 被引量:6
  • 3杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1188
  • 4Wajchenberg BL. β-cell failure in diabetes and preservation by clinical treatment[J].ENDOCRINE REVIEWS,2007,(02):187-218.
  • 5Bonora E. Protection of pancreatic beta-cells:is it feasible[J].Nutrition Metabolism and Cardiovascular Diseases,2008,(01):74-83.
  • 6Gil Leibowitz,Nurit Kaiser,Erol Cerasi. β-cell failure in type 2 diabetes[J].J Diabetes Invest,2011,(02):82-90.
  • 7Choi CS,Kim MY,Han K. Assessment of βcell function in human patients[J].Islets,2012,(02):79-83.
  • 8Luyckx AS,Mendoza E,Lefebvre PJ. Failure of indomethacin to affect ar-ginine-induced C-peptide and glucagon release in insulin-treated diabet-ics.Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine[J].DIABETOLOGIA,1981,(04):376-382.
  • 9Tangphao O,Grossmann M,Chalon S. Pharmacokinetics of intrave-nous and oral L-arginine in normal volunteers[J].British Journal of Clinical Pharmacology(England),1999,(03):261-266.
  • 10John Wahren;橀sa Kallas;Anders AF.The clinical potential of c-peptide replacement in type 1 diabetes[J],DIABETES2012(04):761-772.

共引文献974

同被引文献81

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部